
Congress trades
Tandem Diabetes Care, Inc. (TNDM)
NASDAQ · Healthcare · 8 congress trades · last filed 13 days ago
About Tandem Diabetes Care, Inc.
from the company's filings and listing, as of Oct 22, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- John F. Sheridan
- Employees
- 2,500
- Listed since
- Nov 14, 2013
- Market value
- $1.1B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$0.93
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | -$0.31 | -$0.32 | $254.6M | $255.0M | EPS beat, GAAPRevenue in line |
| Q1 FY2026reported May 7, 2026 | -$0.30 | -$0.46 | $247.2M | $240.4M | EPS beat, GAAPRevenue beat |
| Q4 FY2025reported Feb 19, 2026 | -$0.01 | -$0.05 | $290.4M | $277.0M | EPS beat, GAAPRevenue beat |
| Q3 FY2025reported Nov 6, 2025 | -$0.31 | -$0.31 | $249.3M | $235.8M | EPS in line, GAAPRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | -$0.48 | -$0.40 | $240.7M | $238.6M | EPS missRevenue in line |
| Q1 FY2025reported Apr 30, 2025 | -$0.67 | -$0.60 | $234.4M | $220.3M | EPS missRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 7, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| John SheridanPresident and Chief Executive Officer | $791K | $5.4M | $700K | $6.9M |
| Mark NovaraExecutive Vice President, Chief Commercial Officer | $486K | $1.4M | $301K | $2.2M |
| Leigh VossellerExecutive Vice President, Chief Financial Officer and Treasurer | $486K | $1.4M | $278K | $2.2M |
| Elizabeth GasserExecutive Vice President, Chief Strategy and Product Officer | $464K | $1.0M | $249K | $1.7M |
| Shannon HansenExecutive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary | $464K | $1.0M | $248K | $1.7M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $174.8M | 11,583,125 | +8.3% | 16.94% |
| Sessa Capital Im, L.P. | $77.0M | 5,100,000 | +7.8% | 7.46% |
| Vanguard Portfolio Management LLC | $64.9M | 4,299,667 | +7.7% | 6.29% |
| First Light Asset Management, LLC | $51.1M | 3,383,553 | +157.4% | 4.95% |
| Vanguard Capital Management LLC | $46.7M | 3,096,536 | +1.9% | 4.53% |
| State Street Corp | $43.0M | 2,851,646 | +7.1% | 4.17% |
| Gw&K Investment Management, LLC | $38.8M | 2,569,032 | -4.5% | 3.76% |
| Jennison Associates LLC | $35.2M | 2,331,429 | +40.6% | 3.41% |
| Paradice Investment Management LLC | $30.5M | 2,024,014 | -0.9% | 2.96% |
| Jacobs Levy Equity Management, Inc | $30.3M | 2,006,429 | +31.7% | 2.93% |
| Freestone Grove Partners LP | $28.2M | 1,866,134 | +40.2% | 2.73% |
| Geode Capital Management, LLC | $27.2M | 1,800,797 | +7.2% | 2.63% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Congress trades in TNDM
8 disclosures of 8 on record · median 28d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +5.2%S&P 500 -0.5% · +5.7 pts vs S&P 500 | Sep 29, 2026 | Oct 12, 2026 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -26.6%S&P 500 +11.6% · -38.2 pts vs S&P 500 | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +33.5%S&P 500 +13.6% · +19.8 pts vs S&P 500 | Sep 22, 2025 | Oct 15, 2025 | 23d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -15.5%After the saleS&P 500 +34.0% · -49.5 pts vs S&P 500 | Mar 19, 2025 | Apr 10, 2025 | 22d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -10.6%S&P 500 +31.7% · -42.3 pts vs S&P 500 | Mar 4, 2025 | Apr 7, 2025 | 34d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -57.3%S&P 500 +47.0% · -104.3 pts vs S&P 500 | Aug 5, 2024 | Sep 11, 2024 | 37d |
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | -40.8%After the saleS&P 500 +70.5% · -111.3 pts vs S&P 500 | Jul 12, 2023 | Aug 13, 2023 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -75.5%S&P 500 +91.5% · -167.0 pts vs S&P 500 | May 23, 2022 | Jun 10, 2022 | 18d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in TNDM, filterable by party, chamber, type and account.
Members of Congress reporting a position
2 members · estimate, as of Oct 21, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Oct 21, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded TNDM?
Gilbert Ray Cisneros, Jr., Josh Gottheimer, Daniel S. Goldman and Ro Khanna disclosed TNDM transactions in the filings shown here.
Which members of Congress hold TNDM?
2 members of Congress report a position in TNDM in the estimate we hold as of Oct 21, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are TNDM trades disclosed?
Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
